Roberto Gulminetti

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 371 citations · Full text

Hiv/aids Counselling, Treatment And Prevention, Week 48 +14

Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit

Marta Colaneri, Elena Seminari, Stefano Novati et al. · Clinical Microbiology and Infection · 2020 · 147 citations · Full text

Virus Viability, Rna Contamination, Respiratory Diseases +9

Prevalence of and risk factors for fungal vaginitis caused by non-albicans species

Arsenio Spinillo, Ezio Capuzzo, Roberto Gulminetti et al. · American Journal of Obstetrics and Gynecology · 1997 · 119 citations

Antifungal Agent, Fungal Vaginitis, Vaginitis +10

EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count

Stefania Paolucci, Irene Cassaniti, Federica Novazzi et al. · International Journal of Infectious Diseases · 2020 · 111 citations · Full text

Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients

Stefania Paolucci, L Fiorina, B Mariani et al. · Virology Journal · 2013 · 88 citations · Full text